Skip to main content
2025 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Resident Poster

(11-430) Impact of Dalbavancin Use as a First-line Intravenous Antibiotic in Refractory Cellulitis on Hospital Admissions and Cost

Wednesday, December 10, 2025
12:30 PM - 1:30 PM  
Location: Bayside A, Level 1
Residency Program: St. Peter's Hospital
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: New York
Co-Author(s): Lukas Waller